**Core Concept**
Potassium channel openers and nitric oxide donors are two distinct classes of vasodilatory drugs. Potassium channel openers work by activating ATP-sensitive potassium channels, leading to hyperpolarization of vascular smooth muscle cells and subsequent vasodilation. Nitric oxide donors release nitric oxide, which stimulates guanylyl cyclase to increase cyclic guanosine monophosphate (cGMP) levels, causing smooth muscle relaxation and vasodilation.

**Why the Correct Answer is Right**
The correct answer is a drug that combines both mechanisms. This drug would activate ATP-sensitive potassium channels, leading to hyperpolarization of vascular smooth muscle cells, and simultaneously release nitric oxide, which would increase cGMP levels and cause smooth muscle relaxation. This dual mechanism would result in potent vasodilation.

**Why Each Wrong Option is Incorrect**
**Option A:** This drug is a selective alpha-blocker and does not have potassium channel opening or nitric oxide donating properties.
**Option B:** This drug is a calcium channel blocker, which works by reducing calcium influx into vascular smooth muscle cells, but it does not have potassium channel opening or nitric oxide donating properties.
**Option C:** This drug is a phosphodiesterase inhibitor, which increases cGMP levels by inhibiting its breakdown, but it does not have potassium channel opening or nitric oxide donating properties.

**Clinical Pearl / High-Yield Fact**
A key characteristic of potassium channel openers is their ability to cause vasodilation in the presence of endothelial dysfunction, as they do not require nitric oxide release to produce their effects.

**Correct Answer:** C.